Budesonide Tablet, Film Coated, Extended Release
Product Images NDC 0378-4500

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Budesonide (NDC 0378-4500). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Budesonide Structural Formula (Image 01)

Chemical structure of budesonide, showing its molecular configuration with multiple hydroxyl groups, methyl groups, and an ester side chain, consistent with its corticosteroid class.*

FDA Label Image

Budesonide Extended-release Tablets 9 mg Bottle Label (Image 02)

The label for Budesonide Extended-Release Tablets shows a 9 mg dosage strength. It is an oral, film-coated, extended-release tablet by Mylan Pharmaceuticals Inc. The label includes dosage instructions, storage information, and a 30-tablet count. The package is marked Rx only and features the NDC 0378-4500-93.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.